IMDX Competitors & Alternatives
Compare Insight Molecular Diagnostics Inc. with similar stocks in the same industry
Diagnostics & Research
IMDX
Main Stock$5.40
Tradestie Score
55
Market Cap
$94.16M
Revenue Growth
-1.0%
Analyst Upside
+54.3%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$11.20
|
$1.13B | - | 55 | Compare |
|
CDNA
CareDx, Inc.
|
$25.05
|
$798.40M | - | 68 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$17.84
|
$719.31M | - | 49 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$21.20
|
$667.77M | - | 56 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$10.17
|
$612.76M | - | 54 | Compare |
|
LCTX
Lineage Cell Therapeutics, Inc.
|
$1.26
|
$385.92M | - | 51 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$33.92
|
$62.81M | - | 56 | Compare |
|
SYBX
Synlogic, Inc. Common Stock
|
$0.56
|
$19.89M | - | 37 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$2.94
|
$4.78M | - | 48 | Compare |
|
CLSDQ
CLSDQ
|
- | - | - | - | Compare |
More IMDX Analysis
Data updated: Jun 23, 2026 | Industry: Diagnostics & Research (SIC 2835)
39 stocks in this industry